Käte Franke

934 total citations
19 papers, 748 citations indexed

About

Käte Franke is a scholar working on Anesthesiology and Pain Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Käte Franke has authored 19 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Anesthesiology and Pain Medicine, 5 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Käte Franke's work include Anesthesia and Sedative Agents (8 papers), Ion channel regulation and function (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Käte Franke is often cited by papers focused on Anesthesia and Sedative Agents (8 papers), Ion channel regulation and function (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Käte Franke collaborates with scholars based in United States, France and Canada. Käte Franke's co-authors include David J. Greenblatt, Richard I. Shader, Jan Koch‐Weser, Jerold S. Harmatz, Dean S. MacLaughlin, D J Greenblatt, Elaine Woo, Hermann R. Ochs, Henry J. Pfeifer and Marcia D. Allen and has published in prestigious journals such as New England Journal of Medicine, Circulation and The American Journal of Cardiology.

In The Last Decade

Käte Franke

19 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Käte Franke United States 13 178 144 131 124 116 19 748
Allen A. Lai United States 17 206 1.2× 127 0.9× 197 1.5× 108 0.9× 153 1.3× 25 852
Elaine Woo United States 13 182 1.0× 71 0.5× 89 0.7× 107 0.9× 74 0.6× 22 901
P.L. Morselli France 18 255 1.4× 165 1.1× 275 2.1× 151 1.2× 91 0.8× 44 975
Dean S. MacLaughlin United States 13 223 1.3× 100 0.7× 220 1.7× 93 0.8× 85 0.7× 15 904
D R Abernethy United States 16 149 0.8× 104 0.7× 182 1.4× 204 1.6× 278 2.4× 31 981
C Crevoisier Switzerland 17 148 0.8× 84 0.6× 162 1.2× 133 1.1× 143 1.2× 40 888
J S Harmatz United States 16 228 1.3× 123 0.9× 173 1.3× 192 1.5× 336 2.9× 22 1.0k
Lester C. Mark United States 18 89 0.5× 138 1.0× 116 0.9× 112 0.9× 162 1.4× 46 1.0k
Morselli Pl Italy 16 228 1.3× 125 0.9× 120 0.9× 75 0.6× 48 0.4× 45 682
P. A. Toseland United Kingdom 19 194 1.1× 142 1.0× 246 1.9× 92 0.7× 94 0.8× 66 1.1k

Countries citing papers authored by Käte Franke

Since Specialization
Citations

This map shows the geographic impact of Käte Franke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Käte Franke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Käte Franke more than expected).

Fields of papers citing papers by Käte Franke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Käte Franke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Käte Franke. The network helps show where Käte Franke may publish in the future.

Co-authorship network of co-authors of Käte Franke

This figure shows the co-authorship network connecting the top 25 collaborators of Käte Franke. A scholar is included among the top collaborators of Käte Franke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Käte Franke. Käte Franke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Greenblatt, D J, Richard I. Shader, Käte Franke, et al.. (1980). Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans. Survey of Anesthesiology. 24(1). 14–14. 5 indexed citations
2.
Greenblatt, David J., Richard I. Shader, Käte Franke, et al.. (1979). Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans. Journal of Pharmaceutical Sciences. 68(1). 57–63. 161 indexed citations
3.
Greenblatt, David J., Käte Franke, & Richard I. Shader. (1978). Analysis of lorazepam and its glucoronide metabolite by electron-capture gas—liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 146(2). 311–320. 93 indexed citations
4.
Greenblatt, D J, Richard I. Shader, Käte Franke, & J S Harmatz. (1978). Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses.. PubMed. 16(10). 486–93. 8 indexed citations
5.
Greenblatt, David J., Richard I. Shader, Sorcha MacLeod, et al.. (1978). Absorption of oral and intramuscular chlordiazepoxide. European Journal of Clinical Pharmacology. 13(4). 267–274. 21 indexed citations
6.
Ochs, Hermann R., David J. Greenblatt, Elaine Woo, et al.. (1978). Single and multiple dose pharmacokinetics of oral quinidine sulfate and gluconate. The American Journal of Cardiology. 41(4). 770–777. 32 indexed citations
7.
Greenblatt, D J, Käte Franke, & David H. Huffman. (1978). Impairment of antipyrine clearance in humans by propranolol.. Circulation. 57(6). 1161–1164. 59 indexed citations
8.
Ochs, Hermann R., David J. Greenblatt, Elaine Woo, Käte Franke, & Thomas W. Smith. (1978). Effect of Propranolol on Pharmacokinetics and Acute Electrocardiographic Changes following Intravenous Quinidine in Humans. Pharmacology. 17(6). 301–306. 20 indexed citations
9.
Greenblatt, David J., et al.. (1977). Kinetics of intravenous chlordiazepoxide: Sex differences in drug distribution. Clinical Pharmacology & Therapeutics. 22(6). 893–903. 36 indexed citations
10.
Greenblatt, D J, Henry J. Pfeifer, Hermann R. Ochs, et al.. (1977). Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.. Journal of Pharmacology and Experimental Therapeutics. 202(2). 365–378. 108 indexed citations
11.
Shader, Richard I., David J. Greenblatt, Jerold S. Harmatz, Käte Franke, & Jan Koch‐Weser. (1977). Absorption and Disposition of Chlordiazepoxide in Young and Elderly Male Volunteers. The Journal of Clinical Pharmacology. 17(11). 709–718. 81 indexed citations
12.
Greenblatt, David J., Jerold S. Harmatz, Donald R. Stanski, et al.. (1977). Factors influencing blood concentrations of chlordiazepoxide: A use of multiple regression analysis. Psychopharmacology. 54(3). 277–282. 12 indexed citations
13.
Ochs, Hermann R., David J. Greenblatt, Elaine Woo, Käte Franke, & Thomas W. Smith. (1977). Reduced Clearance of Quinidine in Elderly Humans. PubMed. 43. 426–426. 5 indexed citations
14.
Stanski, D. R., et al.. (1977). PLASMA AND CEREBROSPINAL FLUID CONCENTRATIONS OF CHLORDIAZEPOXIDE AND ITS METABOLITES IN SURGICAL PATIENTS. Survey of Anesthesiology. 21(5). 418–418. 1 indexed citations
15.
Stanski, Donald R., et al.. (1976). Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients. Clinical Pharmacology & Therapeutics. 20(5). 571–578. 18 indexed citations
16.
Greenblatt, David J., Richard I. Shader, Jerold S. Harmatz, Käte Franke, & Jan Koch‐Weser. (1976). Influence of magnesium and aluminum hydroxide mixture on chlordiazepoxide absorption. Clinical Pharmacology & Therapeutics. 19(2). 234–239. 32 indexed citations
17.
Sokol, Gerald H., David J. Greenblatt, Philip Littman, Käte Franke, & Jan Koch‐Weser. (1975). Chlordiazepoxide Metabolism in Mice following Hepatic Irradiation. Pharmacology. 13(3). 248–251. 3 indexed citations
18.
Greenblatt, D J, Richard I. Shader, Jan Koch‐Weser, & Käte Franke. (1975). Clinical pharmacokinetics of chlordiazepoxide.. PubMed. 11(4). 34–5. 17 indexed citations
19.
Greenblatt, David J., Richard I. Shader, Jan Koch‐Weser, & Käte Franke. (1974). Slow Absorption of Intramuscular Chlordiazepoxide. New England Journal of Medicine. 291(21). 1116–1118. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allen A. Lai Breakdown of academic impact, for papers by Elaine Woo Breakdown of academic impact, for papers by P.L. Morselli Breakdown of academic impact, for papers by Dean S. MacLaughlin Breakdown of academic impact, for papers by D R Abernethy Breakdown of academic impact, for papers by C Crevoisier Breakdown of academic impact, for papers by J S Harmatz Breakdown of academic impact, for papers by Lester C. Mark Breakdown of academic impact, for papers by Morselli Pl Breakdown of academic impact, for papers by P. A. Toseland
Rankless by CCL
2026